nodes	percent_of_prediction	percent_of_DWPC	metapath
Anagrelide—PDE3A—cGMP effects—KCNMA1—autistic disorder	0.0888	0.0888	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—KCNMA1—autistic disorder	0.0706	0.0706	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—PECAM1—autistic disorder	0.0421	0.0421	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—KCNMA1—autistic disorder	0.0275	0.0275	CbGpPWpGaD
Anagrelide—PDE3A—Nitric oxide stimulates guanylate cyclase—NOS2—autistic disorder	0.0255	0.0255	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—PDE4A—autistic disorder	0.02	0.02	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—PER1—autistic disorder	0.0185	0.0185	CbGpPWpGaD
Anagrelide—CYP1A2—Aflatoxin B1 metabolism—GSTM1—autistic disorder	0.0184	0.0184	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—VIP—autistic disorder	0.0181	0.0181	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—SCT—autistic disorder	0.0173	0.0173	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—TDO2—autistic disorder	0.0169	0.0169	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—ADM—autistic disorder	0.0165	0.0165	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—PDE4B—autistic disorder	0.0161	0.0161	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—DOCK4—autistic disorder	0.0159	0.0159	CbGpPWpGaD
Anagrelide—CYP1A2—Methylation—COMT—autistic disorder	0.0151	0.0151	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—JMJD1C—autistic disorder	0.0141	0.0141	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—PLA2G4A—autistic disorder	0.0129	0.0129	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—DRD1—autistic disorder	0.0129	0.0129	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—ASMT—autistic disorder	0.0128	0.0128	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—CALCA—autistic disorder	0.0121	0.0121	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—ADRB2—autistic disorder	0.0101	0.0101	CbGpPWpGaD
Anagrelide—PDE3A—Platelet homeostasis—NOS2—autistic disorder	0.00993	0.00993	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—AVP—autistic disorder	0.00951	0.00951	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PECAM1—autistic disorder	0.00944	0.00944	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—COMT—autistic disorder	0.00944	0.00944	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—UBE3A—autistic disorder	0.00926	0.00926	CbGpPWpGaD
Anagrelide—CYP1A2—Estrogen metabolism—GSTM1—autistic disorder	0.00863	0.00863	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—MAOB—autistic disorder	0.00791	0.00791	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—NF1—autistic disorder	0.00791	0.00791	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GSTM5—autistic disorder	0.00762	0.00762	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—MAOA—autistic disorder	0.0064	0.0064	CbGpPWpGaD
Anagrelide—PDE3A—G alpha (s) signalling events—POMC—autistic disorder	0.00632	0.00632	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR5A—autistic disorder	0.0062	0.0062	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—KCNMA1—autistic disorder	0.00616	0.00616	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR5A—autistic disorder	0.00563	0.00563	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GABBR2—autistic disorder	0.00527	0.00527	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—MAOB—autistic disorder	0.00518	0.00518	CbGpPWpGaD
Anagrelide—CYP1A2—Melatonin metabolism and effects—APOE—autistic disorder	0.00485	0.00485	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CYP19A1—autistic disorder	0.00479	0.00479	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GABBR2—autistic disorder	0.00478	0.00478	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR1D—autistic disorder	0.0047	0.0047	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GSTM5—autistic disorder	0.00446	0.00446	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—TF—autistic disorder	0.00445	0.00445	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—GSTM5—autistic disorder	0.0044	0.0044	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GRM8—autistic disorder	0.00437	0.00437	CbGpPWpGaD
Anagrelide—CYP1A2—Tryptophan metabolism—CAT—autistic disorder	0.00432	0.00432	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR1D—autistic disorder	0.00426	0.00426	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PDE4A—autistic disorder	0.00411	0.00411	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IL5—autistic disorder	0.00397	0.00397	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GRM8—autistic disorder	0.00396	0.00396	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—autistic disorder	0.00387	0.00387	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AVPR1A—autistic disorder	0.00384	0.00384	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—WNT2—autistic disorder	0.00384	0.00384	CbGpPWpGaD
Anagrelide—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—autistic disorder	0.00382	0.00382	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PLA2G4A—autistic disorder	0.00381	0.00381	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ITGA4—autistic disorder	0.00379	0.00379	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PDE4A—autistic disorder	0.00373	0.00373	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—VIP—autistic disorder	0.00371	0.00371	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GRM5—autistic disorder	0.00371	0.00371	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—GPX1—autistic disorder	0.00365	0.00365	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—OXTR—autistic disorder	0.0036	0.0036	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—SCT—autistic disorder	0.00356	0.00356	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AVPR1A—autistic disorder	0.00349	0.00349	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NRP2—autistic disorder	0.00347	0.00347	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PLAUR—autistic disorder	0.00345	0.00345	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—GABBR1—autistic disorder	0.0034	0.0034	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—ADM—autistic disorder	0.0034	0.0034	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GRM5—autistic disorder	0.00337	0.00337	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—VIP—autistic disorder	0.00337	0.00337	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR5A—autistic disorder	0.00332	0.00332	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PDE4B—autistic disorder	0.00331	0.00331	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—OXTR—autistic disorder	0.00327	0.00327	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—SCT—autistic disorder	0.00323	0.00323	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—OPRM1—autistic disorder	0.0032	0.0032	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—autistic disorder	0.00314	0.00314	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—GABBR1—autistic disorder	0.00308	0.00308	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—ADM—autistic disorder	0.00308	0.00308	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IGF2—autistic disorder	0.00307	0.00307	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PDE4B—autistic disorder	0.003	0.003	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—OPRM1—autistic disorder	0.00291	0.00291	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PLA2G4A—autistic disorder	0.0029	0.0029	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—autistic disorder	0.0029	0.0029	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR1B—autistic disorder	0.00285	0.00285	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—OXT—autistic disorder	0.00285	0.00285	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GABBR2—autistic disorder	0.00283	0.00283	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—MAOB—autistic disorder	0.00275	0.00275	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—ITGB3—autistic disorder	0.00275	0.00275	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—COMT—autistic disorder	0.00265	0.00265	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD1—autistic disorder	0.00265	0.00265	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GSTP1—autistic disorder	0.00264	0.00264	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR1B—autistic disorder	0.00258	0.00258	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—OXT—autistic disorder	0.00258	0.00258	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—DRD3—autistic disorder	0.00256	0.00256	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR1D—autistic disorder	0.00252	0.00252	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL5—autistic disorder	0.00251	0.00251	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—CALCA—autistic disorder	0.00248	0.00248	CbGpPWpGaD
Anagrelide—CYP1A2—Phase II conjugation—GSTM1—autistic disorder	0.00243	0.00243	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRLR—autistic disorder	0.00243	0.00243	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD1—autistic disorder	0.0024	0.0024	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—autistic disorder	0.0024	0.0024	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GRM8—autistic disorder	0.00234	0.00234	CbGpPWpGaD
Anagrelide—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—autistic disorder	0.00233	0.00233	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—DRD3—autistic disorder	0.00233	0.00233	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—autistic disorder	0.0023	0.0023	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL5—autistic disorder	0.00228	0.00228	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—WNT2—autistic disorder	0.00227	0.00227	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PRKCB—autistic disorder	0.00225	0.00225	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—CALCA—autistic disorder	0.00225	0.00225	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GHR—autistic disorder	0.00223	0.00223	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—NOS2—autistic disorder	0.00222	0.00222	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PDE4A—autistic disorder	0.0022	0.0022	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—PIK3CG—autistic disorder	0.00215	0.00215	CbGpPWpGaD
Anagrelide—CYP1A2—Arachidonic acid metabolism—PTGS2—autistic disorder	0.00215	0.00215	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—EGF—autistic disorder	0.00213	0.00213	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—autistic disorder	0.00213	0.00213	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—DHCR7—autistic disorder	0.00212	0.00212	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—ADRB2—autistic disorder	0.00208	0.00208	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AVPR1A—autistic disorder	0.00206	0.00206	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—VIP—autistic disorder	0.00199	0.00199	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GRM5—autistic disorder	0.00199	0.00199	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IGF1—autistic disorder	0.00197	0.00197	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—AVP—autistic disorder	0.00195	0.00195	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—OXTR—autistic disorder	0.00193	0.00193	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SCT—autistic disorder	0.00191	0.00191	CbGpPWpGaD
Anagrelide—CYP1A2—Phase 1 - Functionalization of compounds—POMC—autistic disorder	0.00189	0.00189	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—ADRB2—autistic disorder	0.00188	0.00188	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—SERPINE1—autistic disorder	0.00187	0.00187	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ADM—autistic disorder	0.00182	0.00182	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GABBR1—autistic disorder	0.00182	0.00182	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—EIF4E—autistic disorder	0.00179	0.00179	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PDE4B—autistic disorder	0.00178	0.00178	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—AVP—autistic disorder	0.00177	0.00177	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—OPRM1—autistic disorder	0.00172	0.00172	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—CYP19A1—autistic disorder	0.00167	0.00167	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PLA2G4A—autistic disorder	0.00167	0.00167	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—CYP19A1—autistic disorder	0.00165	0.00165	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—autistic disorder	0.00163	0.00163	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—HTR2A—autistic disorder	0.00162	0.00162	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—GZMB—autistic disorder	0.00157	0.00157	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—COMT—autistic disorder	0.00155	0.00155	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GSTP1—autistic disorder	0.00154	0.00154	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—MAOA—autistic disorder	0.00154	0.00154	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—COMT—autistic disorder	0.00153	0.00153	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR1B—autistic disorder	0.00153	0.00153	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—OXT—autistic disorder	0.00153	0.00153	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—GSTP1—autistic disorder	0.00152	0.00152	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—IL2—autistic disorder	0.00152	0.00152	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HTR2A—autistic disorder	0.00147	0.00147	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PRKCB—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TSC1—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD1—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—GSTM1—autistic disorder	0.00142	0.00142	CbGpPWpGaD
Anagrelide—CYP1A2—Metapathway biotransformation—GSTM1—autistic disorder	0.0014	0.0014	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—NTRK2—autistic disorder	0.00138	0.00138	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—DRD3—autistic disorder	0.00137	0.00137	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—PIK3CG—autistic disorder	0.00136	0.00136	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL5—autistic disorder	0.00135	0.00135	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—NPAS2—autistic disorder	0.00134	0.00134	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—CALCA—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ACADSB—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—INPP1—autistic disorder	0.00133	0.00133	CbGpPWpGaD
Anagrelide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—autistic disorder	0.00131	0.00131	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—POMC—autistic disorder	0.0013	0.0013	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PRKCB—autistic disorder	0.00129	0.00129	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—PIK3CG—autistic disorder	0.00124	0.00124	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—BTD—autistic disorder	0.00118	0.00118	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—POMC—autistic disorder	0.00118	0.00118	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRL—autistic disorder	0.00117	0.00117	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—MAPK1—autistic disorder	0.00116	0.00116	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—RORA—autistic disorder	0.00113	0.00113	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ADRB2—autistic disorder	0.00111	0.00111	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—AVP—autistic disorder	0.00105	0.00105	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IGF2—autistic disorder	0.00104	0.00104	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TDO2—autistic disorder	0.00101	0.00101	CbGpPWpGaD
Anagrelide—CYP1A2—Biological oxidations—POMC—autistic disorder	0.001	0.001	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PLA2G4A—autistic disorder	0.000984	0.000984	CbGpPWpGaD
Anagrelide—PDE3A—GPCR downstream signaling—IL2—autistic disorder	0.000958	0.000958	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MEF2C—autistic disorder	0.000957	0.000957	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DHCR7—autistic disorder	0.000946	0.000946	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—ITGB3—autistic disorder	0.000932	0.000932	CbGpPWpGaD
Anagrelide—PDE3A—Hemostasis—HRAS—autistic disorder	0.000931	0.000931	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—EXT1—autistic disorder	0.000897	0.000897	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC6A8—autistic disorder	0.000897	0.000897	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HTR2A—autistic disorder	0.000871	0.000871	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL2—autistic disorder	0.00087	0.00087	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DAO—autistic disorder	0.000855	0.000855	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—TSC2—autistic disorder	0.000827	0.000827	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—UPB1—autistic disorder	0.00082	0.00082	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APOE—autistic disorder	0.000809	0.000809	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—LEP—autistic disorder	0.000809	0.000809	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PRKCB—autistic disorder	0.000763	0.000763	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ASMT—autistic disorder	0.000762	0.000762	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GSTM5—autistic disorder	0.000762	0.000762	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—APC—autistic disorder	0.00073	0.00073	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PIK3CG—autistic disorder	0.00073	0.00073	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—EGF—autistic disorder	0.000722	0.000722	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC25A12—autistic disorder	0.000717	0.000717	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—SLC19A1—autistic disorder	0.000697	0.000697	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—POMC—autistic disorder	0.000695	0.000695	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IGF1—autistic disorder	0.000669	0.000669	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—MAPK1—autistic disorder	0.000666	0.000666	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	0.000641	0.000641	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—SERPINE1—autistic disorder	0.000635	0.000635	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ADSL—autistic disorder	0.000621	0.000621	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—XDH—autistic disorder	0.000609	0.000609	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—STX1A—autistic disorder	0.000598	0.000598	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—NPAS2—autistic disorder	0.000598	0.000598	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TCN2—autistic disorder	0.000578	0.000578	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—ADA—autistic disorder	0.000551	0.000551	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	0.000545	0.000545	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—HRAS—autistic disorder	0.000534	0.000534	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	0.000522	0.000522	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL2—autistic disorder	0.000514	0.000514	CbGpPWpGaD
Anagrelide—PDE3A—Signaling by GPCR—IL6—autistic disorder	0.000511	0.000511	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—RORA—autistic disorder	0.000503	0.000503	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—PTEN—autistic disorder	0.000484	0.000484	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MAOB—autistic disorder	0.000471	0.000471	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	0.000448	0.000448	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—TPH2—autistic disorder	0.000438	0.000438	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DPYD—autistic disorder	0.000431	0.000431	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	0.000405	0.000405	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CACNA1C—autistic disorder	0.0004	0.0004	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—MAPK1—autistic disorder	0.000393	0.000393	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	0.000385	0.000385	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—DHFR—autistic disorder	0.000364	0.000364	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—HRAS—autistic disorder	0.000316	0.000316	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	0.000307	0.000307	CbGpPWpGaD
Anagrelide—PDE3A—Signaling Pathways—IL6—autistic disorder	0.000302	0.000302	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CYP19A1—autistic disorder	0.000285	0.000285	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	0.000268	0.000268	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—COMT—autistic disorder	0.000265	0.000265	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GSTP1—autistic disorder	0.000264	0.000264	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MAOA—autistic disorder	0.000263	0.000263	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—CAT—autistic disorder	0.000257	0.000257	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PLA2G4A—autistic disorder	0.000243	0.000243	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GSTM1—autistic disorder	0.000243	0.000243	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—GPX1—autistic disorder	0.000232	0.000232	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—MTHFR—autistic disorder	0.000214	0.000214	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—APOE—autistic disorder	0.0002	0.0002	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PIK3CG—autistic disorder	0.00018	0.00018	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—POMC—autistic disorder	0.000171	0.000171	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTGS2—autistic disorder	0.000137	0.000137	CbGpPWpGaD
Anagrelide—CYP1A2—Metabolism—PTEN—autistic disorder	0.000119	0.000119	CbGpPWpGaD
